TrialHuman vaccines & immunotherapeutics2026
Sustained salivary IgG but short-lived IgA responses following primary and booster MenACWY-TT vaccination in older adults.
Maxime Visser et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it